COMMUNIQUÉS West-GlobeNewswire

New Ebook Offers First-Time Biotech CEOs a Roadmap for the Decisions That Determine Company Success
17/12/2025
Produced by KreaMedica, in partnership with Venture Valuation and Lacerta Bio: three leading advisors to early-stage biotechs MONTREAL, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Three of the biotech industry’s trusted advisory [...]
Inventiva présentera à la 44e conférence annuelle J.P. Morgan Healthcare
17/12/2025
Daix (France), New York City (New York, États-Unis ), le 17 décembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Inventiva to Present at the 44th Annual J.P. Morgan Healthcare Conference
17/12/2025
Daix (France), New York City (New York, United States), December 17, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA ) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the [...]
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
17/12/2025
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings Breadth of Scientific Evidence: The [...]
Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
17/12/2025
SOUTH SAN FRANCISCO, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug [...]
Immuneering Advances Towards Dosing First Patient in Phase 3 Atebimetinib Trial for First-Line Metastatic Pancreatic Cancer Patients, Securing Alignment with FDA and EMA
17/12/2025
– End-of-Phase 2 interactions with FDA complete; scientific advice received from EMA – – Company expects to dose first patient in global Phase 3 registrational trial, MAPKeeper 301, in mid-2026 – – Overall survival [...]
CancerVax Reports Nanoparticle Component Success in Preparation for Animal Studies
17/12/2025
In-vitro studies confirmed strong uptake of cell-targeting nanoparticles by cancer cells and strong activation of Smart mRNAs inside cancer cells Lehi, Utah, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah, December 17, [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
17/12/2025
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 17 déc. 2025 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext [...]
Voting Rights and Shares Capital of the Company
17/12/2025
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Dec. 17, 2025 (GLOBE NEWSWIRE [...]
Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders
17/12/2025
HONG KONG, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ: HKPD) ("HKPD" or the "Company"), a leading provider of over the counter (“OTC”) pharmaceutical cross-border e- [...]
Aveanna to Participate at the 44th Annual J.P. Morgan Healthcare Conference
17/12/2025
ATLANTA, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the 44 th Annual J.P. Morgan Healthcare Conference in San [...]
Sapu BioScience Highlights TGFB2-Guided Strategy to Enhance Taxane Therapies, Reinforcing the Rationale for Sapu-001
17/12/2025
San Diego, CA, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Sapu BioScience today announced the publication of a new peer-reviewed study in the International Journal of Molecular Sciences that strengthens the scientific foundation [...]
Zelluna Reaches Major Milestone and Submits Clinical Trial Application in the UK for First-in-Human Study of ZI-MA4-1 (ZIMA-101), the World’s First MAGE-A4-Targeting TCR-NK Cell Therapy for Solid Tumours
17/12/2025
On track for initial clinical data in mid-2026 Marks a pivotal step toward scalable, accessible, off-the-shelf cell therapies for solid tumours Oslo, Norway, 17 December 2025 – Zelluna (OSE: ZLNA), a company pioneering [...]
Singlera Genomics announces research collaboration with the University of Pittsburgh to advance pancreatic cancer early detection
17/12/2025
LA JOLLA, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, with their partner Breakthrough Genomics, a leader [...]
Transparency Notification from Shareholders
17/12/2025
Ghent, Belgium, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Transparency Notification from Shareholders PRESS RELEASE REGULATED INFORMATION 17 December 2025, 6:00 pm CET Ghent, Belgium – 17 December 2025 – Sequana Medical NV ( [...]
DeLorean AI Releases New Cardiovascular AI White Paper Showing Predictive AI Can Prevent Heart Failure and Cut Costs by Up to $350,000 Per Patient
17/12/2025
Clinically validated platform delivers predictive precision, empowering clinicians with real-time visibility to reduce preventable complications and improve patient outcomes PALM BEACH, Fla., Dec. 17, 2025 (GLOBE [...]
OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates
17/12/2025
No Shareholder Action Required at This Time BETHLEHEM, Pa., Dec. 17, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure” and “OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and [...]
BioNTX Celebrates 2025 Rising Stars Driving North Texas’ Life Science Innovation
17/12/2025
Plano, Texas, Dec. 17, 2025 (GLOBE NEWSWIRE) -- As 2025 comes to a close, BioNTX reflects on a year of innovation, growth, and achievement across North Texas’ life science ecosystem, highlighted by the accomplishments [...]
Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference
17/12/2025
SOUTH SAN FRANCISCO, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today [...]

Pages